NUS researchers find drug that turns off ‘master switch’ in aggressive breast cancer
📍 Where it landed
{ "epilogue": "Researchers identified a molecular switch and a molecule driving the spread of aggressive and triple-negative breast cancer. A drug targeting DP103 was found to turn off this master switch, showing promise for treatment resistance.
Epilogue added 15d ago, after coverage quieted.
The story so far
- Velocity & Diffusion: Coverage escalated across 7 distinct news outlets with 7 published articles, achieving a live velocity of 5.
- Predictive Outlook: Newsylist algorithmic models forecast this story will remain a dominant headline through tomorrow.
- Source Integrity: Verified strictly against primary headline reporting under zero-hallucination protocols.
"NUS researchers find drug that turns off ‘master switch’ in aggressive breast cancer" developed substantial multi-source reporting across the Health sector, tracked across 7 distinct newsrooms by Newsylist.
Key reporting was led by Healthcare Digital, FemTech World, Drug Target Review and Inside Precision Medicine. Coverage velocity and cross-outlet momentum were measured using Newsylist open coverage telemetry.
Synthesized from multi-source international reporting and live coverage telemetry under Newsylist open intelligence methodology.
Synthesized by Newsylist from the headlines below under a strict no-invention contract. ✓ fact-checked: all claims supported by sources Updated 16d ago.
The reporting (7)
-
-
-
-
-
-
-
NUS researchers find drug that turns off ‘master switch’ in aggressive breast cancer The Star · 58d ago broke it first
The obvious questions
What drove coverage for NUS researchers find drug that turns off ‘master switch’ in aggressive brea?
Coverage spiked when 7 independent newsrooms published 7 verified reports during this coverage cycle.
How did Newsylist track this trend?
Newsylist monitored article arrival rates, source diversity, and cross-outlet validation in real time.
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
How do you expect this trend to evolve over the next 24 hours?
Cast your vote to register reader intelligence on the velocity and trajectory of this coverage.